Healthcare Marketing Blogs
09|03|25
Evolving Search Engine Marketing in Pharma: A New Era of Targeting Capabilities
A Google update marks a major shift for pharma marketers, enabling the use of first-party data tools like Customer Match and Remarketing, capabilities previously restricted in sensitive categories. These changes open new doors for precision targeting of HCPs and improved ROI in paid search. Download the POV to learn how your brand can stay competitive in this evolving landscape.
08|28|25
Marketing in the Age of Uncertainty: Preparing for a Post-DTC World
As proposed legislation threatens to ban direct-to-consumer (DTC) pharmaceutical advertising, our experts offer a timely perspective on how pharma marketers can navigate this evolving landscape. In an era defined by regulatory uncertainty and shifting patient expectations, this POV outlines actionable strategies to stay compliant, connected and competitive. Download the POV to discover how marketers can lead the next chapter of healthcare engagement with agility and purpose.
08|26|25
EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access
EVERSANA and Waltz Health today announced a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access. The move integrates Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model into EVERSANA’s global commercialization services, creating a next-generation approach for drug access and value in the U.S. healthcare system.
08|15|25
Reimagining Omnichannel: A New Blueprint for Pharma Marketing
Dan Gandor, EVP, Head of Omnichannel and Digital Transformation, is leading the conversation on what modern pharma marketing should look like. In a recent article in Pharmaceutical Commerce, he shared his insights on how omnichannel strategy has evolved, from fragmented tactics to orchestrated, customer-first experiences. Read the blog to learn more.
08|04|25
EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology
CHICAGO – August 4, 2025 – EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today launched a groundbreaking pharmaceutical marketing AI agency running on an end-to-end AI-powered delivery platform built on Google Cloud technology. The AI Agency, actively deployed and validated for multiple pharmaceutical brands, is 80% AI-powered and automated, reducing marketing costs and […]
07|10|25
Cannes 2025: How CMOs Define The Future of Work and What’s to Come
Each year, the Cannes Lions International Festival of Creativity brings together the world’s most visionary marketers—and 2025 was no exception. Among the attendees was Angela Tenuta, Global Group President at EVERSANA INTOUCH, who shared her reflections in a recent PharmaLive article after joining peers from around the world to explore the evolving role of marketing leadership.
07|01|25
Cannes 2025: Lessons in Branding, AI and the Rise of Creator Content
In his PharmaLive article, John Kenny explores how brands have shifted from speculating about AI to integrating it into creative workflows. From collapsing production timelines to evolving influencer content, discover how AI is reshaping pharma marketing.
06|24|25
Cannes 2025: Pharma’s Creative Inflection Point
In her latest PharmaLive article, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, reflects on three key themes from this year’s Cannes Lions Festival of Creativity—each signaling a new era for pharmaceutical marketing.
06|16|25
MM+M Top 100 2025: Evolved for Where Pharma’s Going
Discover how EVERSANA INTOUCH secured a top 10 spot in the MM+M Agency 100 list and learn how we've evolved for where pharma's going with a unique approach to pharma marketing.
06|13|25
AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era
At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]